Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04666740
Title A Study of Pembrolizumab and Olaparib for People With Metastatic Pancreatic Ductal Adenocarcinoma and Homologous Recombination Deficiency or Exceptional Treatment Response to Platinum-Based Therapy
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Memorial Sloan Kettering Monmouth (All protocol activities) Middletown New Jersey 07748 United States Details
Memorial Sloan Kettering Bergen (All protocol activities) Montvale New Jersey 07645 United States Details
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (All protocol activities) Commack New York 11725 United States Details
Memorial Sloan Kettering Basking Ridge (All protocol activities) New York New York 10065 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Memorial Sloan Kettering Nassau (All protocol activities) Rockville Centre New York 11553 United States Details
Memorial Sloan Kettering Westchester (All Protocol Activities) West Harrison New York 10604 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field